Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
jueves, noviembre 19
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Encompass Health Corp
EHC
NYSE
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$134.93
-2.95
-2.14%
al cierre: Nov 18, 4:00 PM EST
$134.93
-2.95
-2.14%
Premercado: 4:17 AM EST
Get Report
Panorámica general
Noticias
Gráficos
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Dividendos
Comparar
Opciones
Informe de acciones
Encompass Health Financials
Encompass Health (EHC) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Encompass Health Says Sea Pines Rehabilitation Hospital Closed Indefinitely After Torrential Rains; Co. Reaffirms FY26 Guidance Provided On Oct. 28
On Nov. 1-2, 2026, sustained torrential rains led to the flooding, evacuation and closure of Sea Pines Rehabilitation Hospital in Melbourne, Florida ("Sea Pines"). Sea Pines is a 90-bed hospital owned by a joint
Benzinga Newsdesk
PRO
Encompass Health Raises FY2026 Adj EPS Guidance from $6.02-$6.25 to $6.23-$6.37 vs $6.11 Est; Raises FY2026 Sales Guidance from $6.410B-$6.490B to $6.450B-$6.500B vs $6.460B Est
Encompass Health (NYSE:EHC) raises FY2026 Adj EPS guidance from $6.02-$6.25 to $6.23-$6.37 vs $6.11 analyst estimate. Raises FY2026 sales outlook from $6.410 billion-$6.490 billion to $6.450 billion-$6.500 billion vs
Benzinga Newsdesk
PRO
Encompass Health Q3 Adj. EPS $1.52 Beats $1.36 Estimate, Sales $1.609B Beat $1.601B Estimate
Encompass Health (NYSE:EHC) reported quarterly earnings of $1.52 per share which beat the analyst consensus estimate of $1.36 by 11.76 percent. This is a 23.58 percent increase over earnings of $1.23 per share from the
Benzinga Newsdesk
PRO
Encompass Health Raises FY2026 Adj EPS Guidance from $5.89-$6.11 to $6.02-$6.25 vs $6.00 Est; Raises FY2026 Sales Guidance from $6.375B-$6.470B to $6.410B-$6.490B vs $6.421B Est
Encompass Health (NYSE:EHC) raises FY2026 Adj EPS guidance from $5.89-$6.11 to $6.02-$6.25 vs $6.00 analyst estimate. Raises FY2026 sales outlook from $6.375 billion-$6.470 billion to $6.410 billion-$6.490 billion vs
Benzinga Newsdesk
PRO
Encompass Health Q2 Adj. EPS $1.55 Beats $1.48 Estimate, Sales $1.597B Beat $1.571B Estimate
Encompass Health (NYSE:EHC) reported quarterly earnings of $1.55 per share which beat the analyst consensus estimate of $1.48 by 4.73 percent. This is a 10.71 percent increase over earnings of $1.40 per share from the
Benzinga Newsdesk
PRO
Encompass Health Raises FY2026 Adj EPS Guidance from $5.81-$6.10 to $5.89-$6.11 vs $6.00 Est; Raises FY2026 Sales Guidance from $6.365B-$6.465B to $6.375B-$6.470B vs $6.423B Est
Encompass Health (NYSE:EHC) raises FY2026 Adj EPS guidance from $5.81-$6.10 to $5.89-$6.11 vs $6.00 analyst estimate. Raises FY2026 sales outlook from $6.365 billion-$6.465 billion to $6.375 billion-$6.470 billion vs
Benzinga Newsdesk